|
1
|
Cossu G, Messerer M, Oddo M and Daniel RT:
To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.
Biomed Res Int. 2014(628597)2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fotakopoulos G, Makris D, Kotlia P,
Kapsalaki E, Papanikolaou J, Georgiadis I, Zakynthinos E and
Fountas K: The value of computed tomography perfusion &
transcranial Doppler in early diagnosis of cerebral vasospasm in
aneurysmal & traumatic subarachnoid hemorrhage. Future Sci OA.
4(FSO313)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ko NU, Rajendran P, Kim H, Rutkowski M,
Pawlikowska L, Kwok PY, Higashida RT, Lawton MT, Smith WS, Zaroff
JG and Young WL: Endothelial nitric oxide synthase polymorphism
(-786T->C) and increased risk of angiographic vasospasm after
aneurysmal subarachnoid hemorrhage. Stroke. 39:1103–1018.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dumont AS, Dumont RJ, Chow MM, Lin CL,
Calisaneller T, Ley KF, Kassell NF and Lee KS: Cerebral vasospasm
after subarachnoid hemorrhage: Putative role of inflammation.
Neurosurgery. 53:123–135. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Foley WD, Smith DF, Milde MW, Lawson TL,
Towne JB and Bandyk DF: Intravenous DSA examination of patients
with suspected cerebral ischemia. Radiology. 151:651–659.
1984.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Muir KW, Baird-Gunning J, Walker L, Baird
T, McCormick M and Coutts SB: Can the ischemic penumbra be
identified on noncontrast CT of acute stroke? Stroke. 38:2485–2490.
2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murphy BD, Fox AJ, Lee DH, Sahlas DJ,
Black SE, Hogan MJ, Coutts SB, Demchuk AM, Goyal M, Aviv RI, et al:
Identification of penumbra and infarct in acute ischemic stroke
using computed tomography perfusion-derived blood flow and blood
volume measurements. Stroke. 37:1771–177. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wintermark M and Warach SJ: Acute stroke
imaging research roadmap II and international survey of acute
stroke imaging capabilities: We need your help! AJNR Am J
Neuroradiol. 34(1671)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Campbell BC, Christensen S, Butcher KS,
Gordon I, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, De
Silva DA, et al: Regional very low cerebral blood volume predicts
hemorrhagic transformation better than diffusion-weighted imaging
volume and thresholded apparent diffusion coefficient in acute
ischemic stroke. Stroke. 41:82–88. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yassi N, Parsons MW, Christensen S, Sharma
G, Bivard A, Donnan GA, Levi CR, Desmond PM, Davis SM and Campbell
BC: Prediction of poststroke hemorrhagic transformation using
computed tomography perfusion. Stroke. 44:3039–3043.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Provenzale JM, Shah K, Patel U and McCrory
DC: Systematic review of CT and MR perfusion imaging for assessment
of acute cerebrovascular disease. AJNR Am J Neuroradiol.
29:1476–1482. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Derex L, Nighoghossian N, Hermier M,
Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC and
Trouillas P: Influence of pretreatment MRI parameters on clinical
outcome, recanalization and infarct size in 49 stroke patients
treated by intravenous tissue plasminogen activator. J Neurol Sci.
225:3–9. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Parsons MW, Barber PA, Chalk J, Darby DG,
Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA and
Davis SM: Diffusion- and perfusionweighted MRI response to
thrombolysis in stroke. Ann Neurol. 51:28–37. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Francoeur CL and Mayer SA: Management of
delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care.
20(277)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Friebe A and Koesling D: Regulation of
nitric oxide-sensitive guanylyl cyclase. Circ Res. 93:96–105.
2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ghofrani HA, Osterloh IH and Grimminger F:
Sildenafil: From angina to erectile dysfunction to pulmonary
hypertension and beyond. Nat Rev Drug Discov. 5:689–702.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Mukherjee KK, Singh SK, Khosla VK,
Mohindra S and Salunke P: Safety and efficacy of sildenafil citrate
in reversal of cerebral vasospasm: A feasibility study. Surg Neurol
Int. 3(3)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Das A, Xi L and Kukreja RC:
Phosphodiesterase-5 inhibitor sildenafil preconditions adult
cardiac myocytes against necrosis and apoptosis. Essential role of
nitric oxide signaling. J Biol Chem. 280:12944–12955.
2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
García-Cardoso J, Vela R, Mahillo E,
Mateos-Cáceres PJ, Modrego J, Macaya C and López-Farré AJ:
Increased cyclic guanosine monophosphate production and endothelial
nitric oxide synthase level in mononuclear cells from sildenafil
citrate-treated patients with erectile dysfunction. Int J Impot
Res. 22:68–76. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gebska MA, Stevenson BK, Hemnes AR,
Bivalacqua TJ, Haile A, Hesketh GG, Murray CI, Zaiman AL, Halushka
MK, Krongkaew N, et al: Phosphodiesterase-5A (PDE5A) is localized
to the endothelial caveolae and modulates NOS3 activity. Cardiovasc
Res. 90:353–363. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Konstantinopoulos A, Giannitsas K,
Athanasopoulos A, Spathas D and Perimenis P: The impact of daily
sildenafil on levels of soluble molecular markers of endothelial
function in plasma in patients with erectile dysfunction. Expert
Opin Pharmacother. 10:155–1560. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Abbott D, Comby P, Charuel C, Graepel P,
Hanton G, Leblanc B, Lodola A, Longeart L, Paulus G, Peters C and
Stadler J: Preclinical safety profile of sildenafil. Int J Impot
Res. 16:498–504. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Conti CR, Pepine CJ and Sweeney M:
Efficacy and safety of sildenafil citrate in the treatment of
erectile dysfunction in patients with ischemic heart disease. Am J
Cardiol. 83:29C–34C. 1999.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fox KM, Thadani U, Ma PT, Nash SD, Keating
Z, Czorniak MA, Gillies H and Keltai M: CAESAR I (Clinical American
and European Studies of Angina and Revascularization)
investigators. Sildenafil citrate does not reduce exercise
tolerance in men with erectile dysfunction and chronic stable
angina. Eur Heart J. 24:2206–2212. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Meier P and Zierler KL: On the theory of
the indicator-dilution method for measurement of blood flow and
volume. J Appl Physiol. 6:731–744. 1954.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Konstas AA, Goldmakher GV, Lee TY and Lev
MH: Theoretic basis and technical implementations of CT perfusion
in acute ischemic stroke, part 1: Theoretic basis. AJNR Am J
Neuroradiol. 30:662–668. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yao GE, Li Q, Jiang XJ, Liu J, Li JL,
Zhang LL, Li LL, Zhang J and Xie P: Vasospasm after subarachnoid
hemorrhage: A 3D rotational angiography study. Acta Neurochir
Suppl. 110:221–225. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cremers CH, van der Schaaf IC, Wensink E,
Greving JP, Rinkel GJ, Velthuis BK and Vergouwen MD: CT perfusion
and delayed cerebral ischemia in aneurysmal subarachnoid
hemorrhage: A systematic review and meta-analysis. J Cereb Blood
Flow Metab. 34:200–207. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kunze E, Pham M, Raslan F, Stetter C, Lee
JY, Solymosi L, Ernestus RI, Vince GH and Westermaier T: Value of
perfusion CT, transcranial doppler sonography, and neurological
examination to detect delayed vasospasm after aneurysmal
subarachnoid hemorrhage. Radiol Res Pract.
2012(231206)2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sanelli PC, Ugorec I, Johnson CE, Tan J,
Segal AZ, Fink M, Heier LA, Tsiouris AJ, Comunale JP, John M, et
al: Using quantitative CT perfusion for evaluation of delayed
cerebral ischemia following aneurysmal subarachnoid hemorrhage.
AJNR Am J Neuroradiol. 32:2047–2053. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Levati A, Solaini C and Boselli L:
Prevention and treatment of vasospasm. J Neurosurg Sci Mar. 42 (1
Suppl 1):S27–S31. 1998.PubMed/NCBI
|
|
32
|
Hansen D, Hannemann L, Specht M and
Schaffartzik W: Cerebral vasospasm following aneurysmal
subarachnoid hemorrhage. Therapeutic value of treatment with
calcium antagonists, hypervolemic hemodilution and induced arterial
hypertension. Anaesthesist. 44:219–229. 1995.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
33
|
Grotenhuis JA and Bettag W: Prevention of
symptomatic vasospasm after SAH by constant venous infusion of
nimodipine. Neurol Res. 8:243–249. 1986.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hänggi D, Beseoglu K, Turowski B and
Steiger HJ: Feasibility and safety of intrathecal nimodipine on
posthaemorrhagic cerebral vasospasm refractory to medical and
endovascular therapy. Clin Neurol Neurosurg. 110:784–790.
2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Geraghty JR and Testai FD: Delayed
cerebral ischemia after subarachnoid hemorrhage: Beyond vasospasm
and towards a multifactorial pathophysiology. Curr Atheroscler Rep.
19(50)2017.PubMed/NCBI View Article : Google Scholar
|
|
|
Maruhashi T and Higashi Y: An overview of
pharmacotherapy for cerebral vasospasm and delayed cerebral
ischemia after subarachnoid hemorrhage. Expert Opin Pharmacother.
22:1601–1614. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ba Y, Zhang C, Huang J, Hua X, Cui T, Zhao
S and Gao G: Microsurgical clipping vs. arterial embolization in
the treatment of ruptured anterior circulation aneurysms. Am J
Transl Res. 13:8040–8048. 2021.PubMed/NCBI
|
|
37
|
Mielke D, Döring K, Behme D, Psychogios
MN, Rohde V and Malinova V: The impact of endovascular rescue
therapy on the clinical and radiological outcome after aneurysmal
subarachnoid hemorrhage: A safe and effective treatment option for
hemodynamically relevant vasospasm? Front Neurol.
13(838456)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Atalay B, Caner H, Cekinmez M, Ozen O,
Celasun B and Altinors N: Systemic administration of
phosphodiesterase V inhibitor, sildenafil citrate, for attenuation
of cerebral vasospasm after experimental subarachnoid hemorrhage.
Neurosurgery. 59:1102–1107. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Adiga A, Edriss H and Nugent K:
Intracranial aneurysm and sildenafil. Proc (Bayl Univ Med Cent).
29:178–1780. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gokce C, Gulsen S, Yilmaz C, Guven G,
Caner H and Altinors N: The effect of the sildenafil citrate on
cerebral vasospasm and apoptosis following experimental
subarachnoid hemorrhage in rats. J Neurosurg Sci. 54:29–37.
2010.PubMed/NCBI
|
|
41
|
Edwards DH, Byrne JV and Griffith TM: The
effect of chronic subarachnoid hemorrhage on basal
endothelium-derived relaxing factor activity in intrathecal
cerebral arteries. J Neurosurg. 76:830–837. 1992.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Inoha S, Inamura T, Ikezaki K, Nakamizo A,
Amano T and Fukui M: Type V phosphodiesterase expression in
cerebral arteries with vasospasm after subarachnoid hemorrhage in a
canine model. Neurol Res. 24:607–612. 2002.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kasuya H, Weir BK, Nakane M, Pollock JS,
Johns L, Marton LS and Stefansson K: Nitric oxide synthase and
guanylate cyclase levels in canine basilar artery after
subarachnoid hemorrhage. J Neurosurg. 82:250–255. 1995.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kim P, Schini VB, Sundt TM Jr and
Vanhoutte PM: Reduced production of cGMP underlies the loss of
endothelium-dependent relaxations in the canine basilar artery
after subarachnoid hemorrhage. Circ Res. 70:248–256.
1992.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Thomas JE and Rosenwasser RH: Reversal of
severe cerebral vasospasm in three patients after aneurysmal
subarachnoid hemorrhage: Initial observations regarding the use of
intraventricular sodium nitroprusside in humans. Neurosurgery.
44:48–58. 1999.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Vellimana AK, Milner E, Azad TD, Harries
MD, Zhou ML, Gidday JM, Han BH and Zipfel GJ: Endothelial nitric
oxide synthase mediates endogenous protection against subarachnoid
hemorrhage-induced cerebral vasospasm. Stroke. 42:776–782.
2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Han BH, Vellimana AK, Zhou ML, Milner E
and Zipfel GJ: Phosphodiesterase 5 inhibition attenuates cerebral
vasospasm and improves functional recovery after experimental
subarachnoid hemorrhage. Neurosurgery. 70:178–187. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sahara M, Sata M, Morita T, Nakajima T,
Hirata Y and Nagai R: A phosphodiesterase-5 inhibitor vardenafil
enhances angiogenesis through a protein kinase G-dependent
hypoxia-inducible factor-1/vascular endothelial growth factor
pathway. Arterioscler Thromb Vasc Biol. 30:1315–1324.
2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Zhang L, Zhang RL, Wang Y, Zhang C, Zhang
ZG, Meng H and Chopp M: Functional recovery in aged and young rats
after embolic stroke: Treatment with a phosphodiesterase type 5
inhibitor. Stroke. 36:847–852. 2005.PubMed/NCBI View Article : Google Scholar
|
